Fragmin/protamine microparticles to adsorb and protect HGF and to function as local HGF carriers in vivo

Satoko Kishimoto, Masayuki Ishihara, Shingo Nakamura, Masanori Fujita, Megumi Takikawa, Yuki Sumi, Tomoharu Kiyosawa, Toshinori Sato, Yasuhiro Kanatani

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The clinical efficacy of hepatocyte growth factor (HGF) in tissue repair can be greatly enhanced by high affinity, biocompatible drug carriers that maintain the bioactivity and regulate release at the target site. We produced 0.5-3.0 μm fragmin (low molecular weight heparin)/protamine microparticles (F/P MPs) as carriers for the controlled release of HGF. F/P MPs immobilized more than 3 μg of HGF per mg of MPs and gradually released the absorbed HGF into the medium with a half-release time of approximately 5 days. Compared with HGF alone, HGF-containing F/P MPs substantially enhanced the mitogenic effect of HGF on cultured human microvascular endothelial cells, by prolonging the biological half-life, and its conjugation to F/P MPs protected HGF from heat and proteolytic inactivation. F/P MPs disappeared 8 days after subcutaneous injection in mice, suggesting that they are rapidly biodegraded. Furthermore, the number of large (diameter ≥200 μm or containing ≥100 erythrocytes) and medium (diameter 20-200 μm or containing 10-100 erythrocytes) lumen capillaries 8 days after injection of HGF-containing F/P MPs was significantly higher than that after injection of HGF or F/P MPs alone. Furthermore, the number of small (diameter ≤20 μm or containing 1-10 erythrocytes) lumen capillaries was significantly higher 4 days after injection of HGF-containing F/P MPs. This increased angiogenic activity of HGF in vivo is probably due to both sustained local release and protection against biodegradation by the F/P MPs. Thus, F/P MPs may be useful and safe HGF carriers that facilitate cell proliferation and vascularization at sites of tissue damage.

Original languageEnglish
Pages (from-to)4763-4770
Number of pages8
JournalActa Biomaterialia
Volume9
Issue number1
DOIs
Publication statusPublished - 2013 Jan

Fingerprint

Dalteparin
Protamines
Hepatocyte Growth Factor
Hepatocytes
Intercellular Signaling Peptides and Proteins
Injections
Erythrocytes
Tissue
Drug Carriers
Erythrocyte Indices
Low Molecular Weight Heparin
Endothelial cells
Cell proliferation
Subcutaneous Injections
Biodegradation
Bioactivity

Keywords

  • Angiogenesis
  • Drug carrier
  • Hepatocyte growth factor
  • Low molecular weight heparin (fragmin)/protamine microparticles

ASJC Scopus subject areas

  • Biomaterials
  • Biomedical Engineering
  • Biotechnology
  • Biochemistry
  • Molecular Biology

Cite this

Kishimoto, S., Ishihara, M., Nakamura, S., Fujita, M., Takikawa, M., Sumi, Y., ... Kanatani, Y. (2013). Fragmin/protamine microparticles to adsorb and protect HGF and to function as local HGF carriers in vivo. Acta Biomaterialia, 9(1), 4763-4770. https://doi.org/10.1016/j.actbio.2012.08.003

Fragmin/protamine microparticles to adsorb and protect HGF and to function as local HGF carriers in vivo. / Kishimoto, Satoko; Ishihara, Masayuki; Nakamura, Shingo; Fujita, Masanori; Takikawa, Megumi; Sumi, Yuki; Kiyosawa, Tomoharu; Sato, Toshinori; Kanatani, Yasuhiro.

In: Acta Biomaterialia, Vol. 9, No. 1, 01.2013, p. 4763-4770.

Research output: Contribution to journalArticle

Kishimoto, S, Ishihara, M, Nakamura, S, Fujita, M, Takikawa, M, Sumi, Y, Kiyosawa, T, Sato, T & Kanatani, Y 2013, 'Fragmin/protamine microparticles to adsorb and protect HGF and to function as local HGF carriers in vivo', Acta Biomaterialia, vol. 9, no. 1, pp. 4763-4770. https://doi.org/10.1016/j.actbio.2012.08.003
Kishimoto, Satoko ; Ishihara, Masayuki ; Nakamura, Shingo ; Fujita, Masanori ; Takikawa, Megumi ; Sumi, Yuki ; Kiyosawa, Tomoharu ; Sato, Toshinori ; Kanatani, Yasuhiro. / Fragmin/protamine microparticles to adsorb and protect HGF and to function as local HGF carriers in vivo. In: Acta Biomaterialia. 2013 ; Vol. 9, No. 1. pp. 4763-4770.
@article{086d2f68ce97442baeb6f0bd3d9cb145,
title = "Fragmin/protamine microparticles to adsorb and protect HGF and to function as local HGF carriers in vivo",
abstract = "The clinical efficacy of hepatocyte growth factor (HGF) in tissue repair can be greatly enhanced by high affinity, biocompatible drug carriers that maintain the bioactivity and regulate release at the target site. We produced 0.5-3.0 μm fragmin (low molecular weight heparin)/protamine microparticles (F/P MPs) as carriers for the controlled release of HGF. F/P MPs immobilized more than 3 μg of HGF per mg of MPs and gradually released the absorbed HGF into the medium with a half-release time of approximately 5 days. Compared with HGF alone, HGF-containing F/P MPs substantially enhanced the mitogenic effect of HGF on cultured human microvascular endothelial cells, by prolonging the biological half-life, and its conjugation to F/P MPs protected HGF from heat and proteolytic inactivation. F/P MPs disappeared 8 days after subcutaneous injection in mice, suggesting that they are rapidly biodegraded. Furthermore, the number of large (diameter ≥200 μm or containing ≥100 erythrocytes) and medium (diameter 20-200 μm or containing 10-100 erythrocytes) lumen capillaries 8 days after injection of HGF-containing F/P MPs was significantly higher than that after injection of HGF or F/P MPs alone. Furthermore, the number of small (diameter ≤20 μm or containing 1-10 erythrocytes) lumen capillaries was significantly higher 4 days after injection of HGF-containing F/P MPs. This increased angiogenic activity of HGF in vivo is probably due to both sustained local release and protection against biodegradation by the F/P MPs. Thus, F/P MPs may be useful and safe HGF carriers that facilitate cell proliferation and vascularization at sites of tissue damage.",
keywords = "Angiogenesis, Drug carrier, Hepatocyte growth factor, Low molecular weight heparin (fragmin)/protamine microparticles",
author = "Satoko Kishimoto and Masayuki Ishihara and Shingo Nakamura and Masanori Fujita and Megumi Takikawa and Yuki Sumi and Tomoharu Kiyosawa and Toshinori Sato and Yasuhiro Kanatani",
year = "2013",
month = "1",
doi = "10.1016/j.actbio.2012.08.003",
language = "English",
volume = "9",
pages = "4763--4770",
journal = "Acta Biomaterialia",
issn = "1742-7061",
publisher = "Elsevier BV",
number = "1",

}

TY - JOUR

T1 - Fragmin/protamine microparticles to adsorb and protect HGF and to function as local HGF carriers in vivo

AU - Kishimoto, Satoko

AU - Ishihara, Masayuki

AU - Nakamura, Shingo

AU - Fujita, Masanori

AU - Takikawa, Megumi

AU - Sumi, Yuki

AU - Kiyosawa, Tomoharu

AU - Sato, Toshinori

AU - Kanatani, Yasuhiro

PY - 2013/1

Y1 - 2013/1

N2 - The clinical efficacy of hepatocyte growth factor (HGF) in tissue repair can be greatly enhanced by high affinity, biocompatible drug carriers that maintain the bioactivity and regulate release at the target site. We produced 0.5-3.0 μm fragmin (low molecular weight heparin)/protamine microparticles (F/P MPs) as carriers for the controlled release of HGF. F/P MPs immobilized more than 3 μg of HGF per mg of MPs and gradually released the absorbed HGF into the medium with a half-release time of approximately 5 days. Compared with HGF alone, HGF-containing F/P MPs substantially enhanced the mitogenic effect of HGF on cultured human microvascular endothelial cells, by prolonging the biological half-life, and its conjugation to F/P MPs protected HGF from heat and proteolytic inactivation. F/P MPs disappeared 8 days after subcutaneous injection in mice, suggesting that they are rapidly biodegraded. Furthermore, the number of large (diameter ≥200 μm or containing ≥100 erythrocytes) and medium (diameter 20-200 μm or containing 10-100 erythrocytes) lumen capillaries 8 days after injection of HGF-containing F/P MPs was significantly higher than that after injection of HGF or F/P MPs alone. Furthermore, the number of small (diameter ≤20 μm or containing 1-10 erythrocytes) lumen capillaries was significantly higher 4 days after injection of HGF-containing F/P MPs. This increased angiogenic activity of HGF in vivo is probably due to both sustained local release and protection against biodegradation by the F/P MPs. Thus, F/P MPs may be useful and safe HGF carriers that facilitate cell proliferation and vascularization at sites of tissue damage.

AB - The clinical efficacy of hepatocyte growth factor (HGF) in tissue repair can be greatly enhanced by high affinity, biocompatible drug carriers that maintain the bioactivity and regulate release at the target site. We produced 0.5-3.0 μm fragmin (low molecular weight heparin)/protamine microparticles (F/P MPs) as carriers for the controlled release of HGF. F/P MPs immobilized more than 3 μg of HGF per mg of MPs and gradually released the absorbed HGF into the medium with a half-release time of approximately 5 days. Compared with HGF alone, HGF-containing F/P MPs substantially enhanced the mitogenic effect of HGF on cultured human microvascular endothelial cells, by prolonging the biological half-life, and its conjugation to F/P MPs protected HGF from heat and proteolytic inactivation. F/P MPs disappeared 8 days after subcutaneous injection in mice, suggesting that they are rapidly biodegraded. Furthermore, the number of large (diameter ≥200 μm or containing ≥100 erythrocytes) and medium (diameter 20-200 μm or containing 10-100 erythrocytes) lumen capillaries 8 days after injection of HGF-containing F/P MPs was significantly higher than that after injection of HGF or F/P MPs alone. Furthermore, the number of small (diameter ≤20 μm or containing 1-10 erythrocytes) lumen capillaries was significantly higher 4 days after injection of HGF-containing F/P MPs. This increased angiogenic activity of HGF in vivo is probably due to both sustained local release and protection against biodegradation by the F/P MPs. Thus, F/P MPs may be useful and safe HGF carriers that facilitate cell proliferation and vascularization at sites of tissue damage.

KW - Angiogenesis

KW - Drug carrier

KW - Hepatocyte growth factor

KW - Low molecular weight heparin (fragmin)/protamine microparticles

UR - http://www.scopus.com/inward/record.url?scp=84870241115&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870241115&partnerID=8YFLogxK

U2 - 10.1016/j.actbio.2012.08.003

DO - 10.1016/j.actbio.2012.08.003

M3 - Article

C2 - 22935325

AN - SCOPUS:84870241115

VL - 9

SP - 4763

EP - 4770

JO - Acta Biomaterialia

JF - Acta Biomaterialia

SN - 1742-7061

IS - 1

ER -